You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AVTX Disposition Disclosure
Sullivan Christopher Ryan · SEC Form 4 · Filed Jun 12, 2026
Disposition
Calculated transaction value
$1.81K
Sullivan Christopher Ryan Chief Financial Officer
AVTX
Avalo Therapeutics
AVTX
Transaction date
Jun 10, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed 2 days later
AVTX daily price context
Close on/before transaction
$13.1
Jun 10, 2026
First close after public filing
$14.6
Jun 15, 2026
30-day return after filing
+29.52%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 138 shares @ $13.1
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001810417-26-000016
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.81K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Avalo Therapeutics, Inc. AVTX Current | Disposition | Jun 10, 2026 | $1.81K |